Sharon Townson
Chief Scientific Officer · Monte Rosa Therapeutics, Inc.
- 2026
- Jul 7, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sharon Townson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Filip Janku - $1.38M in GLUE purchases and sales in the last 12 months
- Markus Warmuth - $951K in GLUE purchases and sales in the last 12 months
- Edmund Dunn - $483K in GLUE purchases and sales in the last 12 months
- Anthony M. Manning - $411K in GLUE purchases and sales in the last 12 months
- Jennifer Champoux - $311K in GLUE purchases and sales in the last 12 months
- Philip Nickson - $151K in GLUE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sharon Townson?
Sharon Townson is a corporate insider, tracked as Chief Scientific Officer of Monte Rosa Therapeutics, Inc. (GLUE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Sharon Townson last file a Form 4?
The most recent primary Form 4 on record is dated 7 July 2026, one of 5 filings going back to 2026.
Has Sharon Townson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($424K) across all tracked filings.
